China: MOFCOM conditionally cleared Baxter’s $4 Billion acquisition of Gambro

Last Updated: 24 August 2013
Article by Susan Ning, Ziqing Zheng and Rui Li

On August 13, 2013, China's Ministry of Commerce (MOFCOM) announced on its website that it has conditionally approved the $4 billion acquisition of Swedish medical technology company Gambro AB by Baxter International.

Baxter is a US-based healthcare company, which develops, manufactures and markets products used in the treatment of patients suffering from hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other acute medical conditions.

Gambro is a Swedish medical technology company, which develops, manufactures and supplies products and treatments for hemodialysis (HD), continuous renal replacement therapy, liver dialysis, myeloma kidney therapy and other extracorporeal treatments for acute medical conditions.

According to the approval condition, Gambro must, sell its global continuous renal replacement therapy (CRRT) business and terminate an OEM production agreement with Japan's Nipro Corporation regarding HD by March 31, 2013.

As the conditional approval was obtained in the middle stage of the extended Phase II, it indicated MOFCOM's commitment and efforts to speed up the review process. In addition, for the first time, the conditional approval conducted an analysis of the post-merger coordination effects between the competitors arising from an OEM production agreement and required the termination of the said agreement.

Review Timeline

On December 31, 2012: First submission was made.

On March 12, 2013: MOFCOM formally accepted the application, Phase I review started.

On April 10, 2013: MOFCOM decided to conduct further review in light of the competition concerns raised, and Phase II review started.

On July 9, 2013: With the consent of the notifying parties, MOFCOM extended the deadline of the review period to September 7, 2013, and the so called extended Phase II review started.

On August 13, 2013: The conditional approval was obtained.

We noticed that during the Phase I review, the parties voluntarily admitted that the proposed transaction would cause competition concerns and submit their proposal for remedies. Such kind of approach is generally welcomed by MOFCOM as this would accelerate the review process if the filing parties play an active role.

Relevant Markets and Competitive Assessment

After taking into consideration the price, methods of treatment and the patients' types, MOFCOM determined the relevant markets are composed of CRRT Monitor, CRRT Dialyzer, and CRRT Blood Line respectively. MOFCOM also investigated the relevant market for HD, another treatment method for kidney dialysis.

MOFCOM found that the proposed transaction would give the merged entity high market share in the relevant market for CRRT Monitor, CRRT Dialyzer and CRRT Blood Line in the China and global market. In addition, after the transaction, the possibility of coordination and lessening of competition will increase in the Chinese HD market since Baxter and Nipro, the two major competitors in the HD market, have OEM agreement in place sharing competitive sensitive information such as costs and quantities.


In light of the competition concerns raised in the CRRT markets and the HD market, MOFCOM imposed conditions and requested Baxter to:

  • Baxter must divest its global CRRT business, including all tangible and intangible assets necessary for the viability and competitiveness of the divested assets;
  • Baxter must completely terminate its OEM production agreement with Nipro regarding HD within China territory by March 31, 2016;
  • Baxter is required to commission a trustee to monitor the fulfillment of its obligation under the conditional approval.

We noticed that the divested CRRT business has excluded the following: research and development facilities, manufacturing assets and a marketing employee who is in charge of Baxter's global CRRT business. In addition, the intellectual property rights to be divested also include free and irrevocable licenses on a patent originally designed for peritoneal dialysis solution but later also used for the production of solution and solution package. All these exemptions show that MOFCOM normally would not try to divest those assets that would affect the parties' other businesses which are unrelated to the product in question.

MOFCOM decision vs EU decision

Although EU's final decision has not been published yet, from the press release issued by EU Commission on July 22, 2013, we can see that it has also approved this transaction subject to conditions. Although the two authorities reached a similar conclusion regarding the divesture of Baxter's CRRT business, EU Commission obtained an additional commitment from Baxter to set up a line for the production of fluids used in CRRT at a location of the purchaser's choice in the European Economic Area or Switzerland.

For the HD market, the difference between the two authorities' decisions is quite obvious. In the MOFCOM's decision, MOFCOM reasoned that after the acquisition of Gambro Baxter and its competitor Nipro would hold a high market share in the HD market in China. The two parities also had an OEM agreement exchanging competitive sensitive information such as cost and quantities. Therefore, it is more likely for Baxter and Gambro to engage in coordinated anticompetitive practices. As a result, MOFCOM ordered the termination of the agreement within China territory. In contrary, EU Commission recognized that Baxter and Gambro are not particularly close competitors in HD and after the merger Baxter will continue to face significant competition in the HD market. Therefore, the EU Commission does not impose any condition to the parties on their HD business.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Related Topics
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Mondaq Sign Up
Gain free access to lawyers expertise from more than 250 countries.
Email Address
Company Name
Confirm Password
Mondaq Newsalert
Select Topics
Select Regions
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions